Variant · Indel
RAD51C NM_058216.3(RAD51C):c.158_160delinsTT (p.Ser53fs)
CI-VAR-00157972Explore in graph →p.Ser53fsNM_058216.3:c.158_160delinsTTClinVar 919784 rs2047940629
Curated evidence
Evidence by cancer (0 items)
Grouped by cancer context first, then therapy. The same variant can be sensitizing in one cancer and irrelevant in another — contexts are never merged. 50 items per page; a cancer group may continue on the next page.
Data not yet available
No curated evidence item references this variant yet.
ClinVar
Clinical significance (1)
ClinVar interpretations are shown as structured records — significance, review status, star rating, conditions — never flattened into one word.
clinvarProvenance
- Source
- NCBI ClinVar (variant_summary)
- Dataset
- ClinVar variant_summary
- Version
- 2026-09-06
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Evidence
- database
- License
- Public domain (US Government work, NCBI/NLM); acknowledgment requested
- Run
- ING-CLINVAR-20260908-000001
| Variation | Clinical significance | Review status | Stars | Conditions | Origin | Submitters | Last evaluated | Source |
|---|---|---|---|---|---|---|---|---|
| 919784 | Pathogenic | criteria provided, multiple submitters, no conflicts | 2 | Hereditary cancer-predisposing syndrome; RAD51C-related disorder; Breast-ovarian cancer, familial, susceptibility to, 3; Fanconi anemia complementation group O; RAD51C-related cancer predisposition | germline | 7 | May 01, 2026 | clinvar |